Keyphrases
Mycosis Fungoides
100%
MicroRNA
100%
Delayed Diagnosis
60%
Disease Progression
60%
Progression-free Survival
40%
Validation Cohort
40%
Clinical Prognostic Factors
40%
Prognostic Potential
20%
Aggressive Treatment
20%
Quantitative PCR
20%
Low-risk Group
20%
Indolent Course
20%
High Risk
20%
MiR-106b-5p
20%
Cutaneous T-cell Lymphoma
20%
Skin Biopsy
20%
Effective Tool
20%
Least Absolute Shrinkage and Selection Operator (LASSO)
20%
MiR-338-3p
20%
Malignancy
20%
Severe Disease
20%
Cox Regression
20%
Prognostic Tool
20%
Poor Prognosis
20%
Overall Survival
20%
MiRNA Expression
20%
High-risk Population
20%
Prognostic Value
20%
Individualized Treatment
20%
Immunology and Microbiology
Progression Free Survival
100%
Overall Survival
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
50%
High Risk Population
50%
T Cell
50%
Low Risk Population
50%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Progression Free Survival
33%
High Risk Population
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Overall Survival
16%
Low Risk Population
16%
T Cell
16%